In gastric cancer, Zhang et al. [40] found that cisplatin and paclitaxel promoted the secretion of miR-522 from CAFs by activating the USP7/hnRNPA1 axis, and ultimately lead to chemotherapy resistance by targeting ALOX15 and blocking the accumulation of lipid ROS in cancer cells. Here, HNRNPA1 is linked to gastric cancer.